Collectively, these results indicate that activation of the NF-κB pathway by bacterial infection is the prerequisite for the observed augmentation of bactericidal activity in BLP-tolerised macrophages, partly via upregulation of membrane-trafficking regulators and lysosomal enzymes. The gene discussed is NFKB1; the disease is bacterial infectious disease.